What should we do about student use of cognitive enhancers? An analysis of current evidence
- 1 January 2013
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 64, 588-595
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- A decade of changeNature Reviews Drug Discovery, 2012
- Risk of caffeine toxicity associated with the use of ‘legal highs’ (novel psychoactive substances)European Journal of Clinical Pharmacology, 2011
- Speeding through the Frat House: A Qualitative Exploration of Nonmedical Adhd Stimulant Use in FraternitiesJournal of Drug Education: Substance Use Research and Prevention, 2010
- “Adderall is Definitely Not a Drug”: Justifications for the Illegal Use of ADHD StimulantsSubstance Use & Misuse, 2009
- Cognitive Enhancement: Methods, Ethics, Regulatory ChallengesScience and Engineering Ethics, 2009
- Nonmedical Use of Prescription Stimulants Among College Students: Associations with Attention‐Deficit‐Hyperactivity Disorder and Polydrug UsePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Neurocognitive enhancement: what can we do and what should we do?Nature Reviews Neuroscience, 2004
- Use of salvia divinorum, an unscheduled hallucinogenic plant: a web-based survey of 500 usersClinical Pharmacology & Therapeutics, 2004
- Comparative Efficacy of Adderall and Methylphenidate in Attention-deficit/Hyperactivity Disorder: A Meta-AnalysisJournal of Clinical Psychopharmacology, 2002
- Student Perceptions of Methylphenidate Abuse at a Public Liberal Arts CollegeJournal of American College Health, 2000